Spark Therapeutics' vision-loss gene therapy to cost $850000 per patient - Reuters

Spark Therapeutics' vision-loss gene therapy to cost $850000 per patient Reuters (Reuters) - Spark Therapeutics Inc said on Wednesday it would charge $850,000 per patient for its gene therapy to treat a rare form of blindness, lesser than analysts' expectation of around $1 million. The company said the list price of the therapy ... and more »

from Health - Google News http://ift.tt/2CARV0T